What OTCPharm JSC does

OTCPharm JSC is a privately held Russian joint-stock company headquartered in Moscow (Testovskaya Street, Presnensky district) that manufactures and sells over-the-counter (OTC) medicines and dietary supplements under the single OTCpharm brand. The company operates its own manufacturing facilities with in-house quality control at every production stage, and explicitly emphasizes compliance with international quality standards alongside continuity of domestic pharmaceutical production traditions. Its addressable market is the Russian OTC and dietary supplements segment, where AlphaRM ranked it a stable leader by sales volume in 2024.

The business model is straightforward consumer-goods manufacturing and distribution: OTCPharm produces finished pharmaceutical SKUs and dietary supplements, then moves them through standard pharmacy and retail distribution channels to end-consumers purchasing for self-medication. Pricing is not publicly disclosed and the company does not appear to sell directly to end-users, contract with named enterprise accounts, or operate subscription or digital channels; all revenue is generated through traditional wholesale-to-retail-to-consumer pharmaceutical supply chains.

The company's strategic posture, as evidenced by its public-facing material, is one of category stewardship rather than disruption: it consolidates around one brand, highlights manufacturing quality and domestic heritage as differentiators, and does not disclose funding rounds, M&A activity, leadership team details, international expansion, AI/ML initiatives, or R&D partnerships. The disclosed employee count of 8 is anomalous for a manufacturer with claimed market leadership, suggesting either a narrowly defined headcount scope or a holding/brand-entity structure rather than a full operating company footprint; this remains unverified in the source data.

Name

OTCPharm JSC

Legal name

OTCPharm JSC

Website

https://otcpharm.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

OTCPharm JSC is a Moscow-based Russian manufacturer of over-the-counter medicines and dietary supplements sold under the OTCpharm brand through pharmacy and retail channels, ranked a stable leader by sales volume in the Russian OTC segment by AlphaRM in 2024.

Ownership category

akta.pro rank

Product category

Over-the-counter pharmaceuticals (OTC medicines and dietary supplements)

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC)

akta.pro secondary industry

Weight Management & Metabolic OTC (HLAIADAI)

Keywords

• Over-the-counter pharmaceuticals
• Dietary supplements
• Pharmaceutical manufacturing
• Consumer health products
• OTC medicines

Headquarters

HQ city

Moscow

HQ country

Russia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. OTC Pharmaceutical Products: Revenue generated from the manufacture and sale of over-the-counter drugs and dietary supplements to consumers and retailers in the Russian market.

Distribution channels1 record

Core offering

OTCPharm JSC manufactures and sells over-the-counter (OTC) medicines and dietary supplements in the Russian market through its own production facility in Moscow. The company produces under the OTCpharm brand, combining modern manufacturing technologies with domestic production traditions and applying international quality standards with quality control at every manufacturing stage. It is recognized as a stable leader in the Russian OTC and dietary supplements segment by sales volume (AlphaRM 2024).

Product overview

OTCPharm JSC is a pharmaceutical company specializing in over-the-counter (OTC) medicines and dietary supplements. The company operates as a single product line under the OTCpharm brand, offering OTC drugs manufactured at their production facilities with quality control at every stage. The company is positioned as a stable market leader in the Russian OTC segment.

Differentiator

Problem solved

Functional benefit

Products and services

• OTCpharm OTC Medicines and Dietary Supplements Over-the-counter (OTC) medicines and dietary supplements produced by OTCPharm JSC at its Moscow manufacturing facility under international quality standards, with quality control at every stage of production. The products are sold to Russian consumers through pharmacy and retail distribution channels for self-medication and general health supplementation needs.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves2 records

Broad incumbents

• STADA Arzneimittel AG: STADA is a European pharmaceutical company with a strong focus on OTC medicines and generics, with significant operations in Russia. It is a broader incumbent competing in the same OTC category as OTCPharm but with a much wider geographic footprint.
• KRKA: KRKA is a Slovenian pharmaceutical manufacturer with a significant OTC and generics portfolio, with established presence in the Russian market. It competes with OTCPharm in the OTC segment with broader international reach.
• Teva Pharmaceutical Industries: Teva is a global pharmaceutical company with a significant OTC and consumer health business. It is a broader incumbent competing in the Russian OTC market with deep product portfolios and global scale.
• Perrigo Company: Perrigo is a global OTC and consumer self-care leader specializing in store-brand and specialty OTC products. It is a broader incumbent operating in the same OTC category as OTCPharm with global scale.
• Sanofi Consumer Healthcare: Sanofi Consumer Healthcare is a global OTC leader with brands like Doliprane, Essentiale, and Maalox. It is a broader incumbent competing in the Russian OTC category with deep R&D and marketing capabilities.
• Polpharma: Polpharma is a Polish pharmaceutical manufacturer with a strong OTC portfolio and presence in Russia and CIS countries. It is a broader incumbent competing in the same OTC space as OTCPharm with regional scale.
• Bayer Consumer Health: Bayer Consumer Health is a global OTC and consumer health leader with brands like Aspirin, Claritin, and Berocca. It is a broader incumbent competing in the Russian OTC category with deep global brand equity and R&D.

Direct peers

• Pharmstandard: Pharmstandard is one of the largest pharmaceutical manufacturers in Russia with a significant OTC portfolio (e.g., Citramon, Pentalgin, Complivit). It is the most directly comparable domestic competitor to OTCPharm in the Russian OTC and dietary supplements market.
• Akrikhin: Akrikhin is a Russian pharmaceutical manufacturer with a strong OTC and consumer health portfolio. It is a directly comparable domestic competitor operating in the same OTC category and pharmacy distribution channels as OTCPharm.
• Valenta Pharm: Valenta Pharm is a major Russian pharmaceutical company specializing in OTC products, dietary supplements, and consumer health brands. It directly competes with OTCPharm in the Russian OTC market with overlapping distribution through pharmacies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/otcpharm-jsc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OTCPharm JSC